Amgen (AMGN) EBT Margin (2009 - 2026)
Amgen (AMGN) recorded EBT Margin of 45.21% in Q3 2026, up 4.18 percentage points from 41.03% a year earlier and up 17.68 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Amgen's EBT Margin came in at 28.41% as of Sep 30, 2026, up 5.49 percentage points year-over-year; for FY2025, it was 24.42%, up 10.63 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -7.57 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 13.79% in FY2024 (-14.07 pp), 27.86% in FY2023 (-0.04 pp), 27.91% in FY2022 (+2.11 pp) and 25.79% in FY2021 (-6.20 pp).
- The Q3 2026 figure is the highest quarterly EBT Margin since Q1 2023.
- On a year-over-year basis, EBT Margin rose in six of the last eight quarters, with an average year-over-year change of +7.11 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 29.53 percentage points in Q1 2023, against a drop of 57.29 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 27.53% (Q2 2026), 24.18% (Q1 2026) and 15.35% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 22.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 45.21% |
| Jun 30, 2026 | 27.53% |
| Mar 31, 2026 | 24.18% |
| Dec 31, 2025 | 15.35% |
| Sep 30, 2025 | 41.03% |
| Jun 30, 2025 | 17.08% |
| Mar 31, 2025 | 24.21% |
| Dec 31, 2024 | 8.61% |
| Sep 30, 2024 | 36.47% |
| Jun 30, 2024 | 9.47% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | 10.40% |
| Sep 30, 2023 | 28.21% |
| Jun 30, 2023 | 23.10% |
| Mar 31, 2023 | 56.38% |
| Dec 31, 2022 | 25.56% |
| Sep 30, 2022 | 35.96% |
| Jun 30, 2022 | 23.22% |
| Mar 31, 2022 | 26.85% |
| Dec 31, 2021 | 31.13% |
API Access
Amgen EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();